This definition appears very rarely
and is found in the following Acronym Finder categories:
- Science, medicine, engineering, etc.
See other meanings of rFSH
We have 4 other definitions for rFSH
in our Acronym Attic
Samples in periodicals archive:
a venture-backed specialty biopharmaceutical company, to develop and commercialize Itero's Recombinant Follicle Stimulating Hormone (rFSH).
New data from an economic analysis presented today at this year's European Society of Human Reproduction and Embryology (ESHRE) congress showed that, within the parameters of the simulation model used, the in vitro fertilisation (IVF) treatment MENOPUR (highly-purified human menopausal gonatropin or HP-hMG) offered considerable cost-savings over recombinant follicle stimulating hormone (rFSH).
Tokyo, Japan, Aug 8, 2005 - (JCNN) - Nippon Organon will launch Follistim 75 and Follistim 150, its proprietary recombinant follicle stimulating hormone (FSH) products used in assisted reproductive treatment, on August 11.
June 7 /PRNewswire/ -- A head-to-head study of MENOPUR(R) (menotropins for injection, USP), highly purified human menopausal gonadotropin (HP-hMG), and Gonal-f(R) (follitropin alpha for injection), recombinant follicle stimulating hormone (rFSH), demonstrated that the ovulation rate with MENOPUR(R) is comparable to that obtained with rFSH in ovulation induction (OI) protocols.
In this trial, patients were treated with either Luveris(R) or placebo, co-administered with Serono's recombinant follicle stimulating hormone (r-hFSH), Gonal-f(R) (follitropin alfa for injection).
For the first time, fertility specialists and patients will be able to use both recombinant hCG and recombinant follicle stimulating hormone (r-hFSH) in the course of a treatment cycle.
It is the first new recombinant molecule to receive marketing authorization for the treatment of infertility since the approval of recombinant follicle stimulating hormone in 1995 with the approval of Serono's Gonal-F(R) (follitropin alfa for injection) by the European Agency for the Evaluation of Medicinal Products (EMEA).
Serono (SWX: SEO) and PowderJect Pharmaceuticals Plc (LSE: PJP) today announced that following the successful completion of initial testing, they have decided to progress the development of Gonal-F(R), recombinant Follicle Stimulating Hormone (FSH), delivered via the PowderJect(R) system into clinical development.